Rituximab-induced tumor cell agglutination

Slides:

Advertisements

Similar presentations

Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis by Thet Thet Lin, Boitelo T. Letsolo,

Advertisements

A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies by Jutta Deckert, Peter U. Park,

Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.

ASH Teaching Slides: Blood Cells

Investigating a New Methodology for the Detection of Low Frequency 17p Deleted Clones in Chronic Lymphocytic Leukaemia (CLL): Impact on Prognostic Outcome.

Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification by Paolo Strati, and.

The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia by Alessandra Ferrajoli, Michael J. Keating,

Chronic lymphocytic leukemia (CLL)

Uncontrolled Wnt signaling causes leukemia

MBL: mostly benign lymphocytes, but…

Next-generation leukemia immunotherapy

by Yoko Otake, Sridharan Soundararajan, Tapas K. Sengupta, Ebenezer A

Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy by Georg.

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease by Marijke R. Canninga-van Dijk, Hanneke.

Retroviral and Chemical Mutagenesis Identifies Pax5 as a Tumor Suppressor in B-Progenitor Acute Lymphoblastic Leukemia by Jinjun Dang, Charles G Mullighan,

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood by Mohamed F. Elshal,

Angiopoietin-2 in CLL by Jan A. Burger Blood Volume 116(4):

Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and.

Mohamed A. Kharfan-Dabaja, Claudio Anasetti, Edgardo S. Santos

Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response by Andreas Rosenwald, Eric Y. Chuang,

Tax fingerprint in adult T-cell leukemia

A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia by John C. Byrd, Guido Marcucci,

by Kumudha Balakrishnan, William G. Wierda, Michael J

Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)

Mutagenic potential of temozolomide in bone marrow cells in vivo

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2 by Christoph Schliemann, Alessandro.

by Laurent O. Mosnier, Andrew J

CD6 Ligation Modulates the Bcl-2/Bax Ratio and Protects Chronic Lymphocytic Leukemia B Cells From Apoptosis Induced by Anti-IgM by Lyda M. Osorio, Angelina.

Targeting kinases in CML CLL

by Rong Chen, Michael J. Keating, Varsha Gandhi, and William Plunkett

Acute promyelocytic leukemia, microgranular variant

Dendritic cells and lymphoma cells: come together right now

by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T

by Sanjai Sharma, and Alan Lichtenstein

CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.

Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells by Aleksandar Petlickovski,

Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis by Dylan.

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Long-Lasting Responses with Lenalidomide As Initial Therapy of Elderly Patients with Chronic Lymphocytic Leukemia (CLL)‏ by Paolo Strati, Michael J. Keating,

by Paolo Strati, Michael J. Keating, William G. Wierda, Xavier C

by Robert McMillan, Jennifer Lopez-Dee, and Joseph C. Loftus

Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells by Sergey Krysov, Samantha Dias, Alex Paterson, C.

Stage C or not stage C…? by Claire Dearden Blood

Chronic neutropenia mediated by Fas ligand

CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not by Naoko Ishibe, Maher Albitar, Iman.

by Beatriz Bellosillo, Mireia Dalmau, Dolors Colomer, and Joan Gil

Vascular endothelial growth factor stimulates protein kinase CβII expression in chronic lymphocytic leukemia cells by Simon T. Abrams, Benjamin R. B. Brown,

LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis by Albert Gutierrez,

by George Z. Rassidakis, Mauricio P. Oyarzo, and L. Jeffrey Medeiros

Anergy: the CLL cell limbo

Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function by Vânia Coelho, Sergey Krysov, Andrew.

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.

Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway by Ludovic.

Induction of chronic lymphocytic leukemia (CLL)–specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells by Martin R. Müller,

Caught in transformation

Supplemental Figure % annexin V-stained cells mean A

by Silvia Mele, Stephen Devereux, Andrea G

724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.

by Geling Li, Emily Waite, and Julie Wolfson

Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses Julia A. Wagner, Melissa.

Cyp8b1−/− mice have improved islet insulin secretion and increased islet insulin content but unchanged β-cell mass. Cyp8b1−/− mice have improved islet.

Early B-cell chronic lymphocytic leukemia presenting as cutaneous lesions with a normal peripheral blood lymphocyte count Simon D.J. Gibbs, MBBS, David.

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Sickle cells and sickle trait in thrombosis

Biology and treatment of Richter syndrome

by Abigail M. Druck Shudofsky, and Chou-Zen Giam

Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) in Elderly Patients with Comorbidities: Analysis of the CLL11.

Initial treatment of CLL: integrating biology and functional status

Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance by Taghi Manshouri, Kim-anh.

Presentation transcript:

Rituximab-induced tumor cell agglutination by Muttuswamy Sivakumaran Blood Volume 100(7):2672-2672 October 1, 2002 ©2002 by American Society of Hematology

Ex vivo agglutination of in vivo antibody-coated chronic lymphocytic leukemia cells (CLLs).Cells incubated in normal saline (control) are shown in panel A, cells incubated in gelofusin showing TCA are shown in panel B, and SEM appearance of agglutinated CLL... Ex vivo agglutination of in vivo antibody-coated chronic lymphocytic leukemia cells (CLLs).Cells incubated in normal saline (control) are shown in panel A, cells incubated in gelofusin showing TCA are shown in panel B, and SEM appearance of agglutinated CLL cells is shown in panel C. Original magnification: × 500. Muttuswamy Sivakumaran Blood 2002;100:2672 ©2002 by American Society of Hematology